Cargando…
SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
The long-term immunity and functional recovery after SARS-CoV-2 infection have implications in preventive measures and patient quality of life. Here we analyzed a prospective cohort of 121 recovered COVID-19 patients from Xiangyang, China at 1-year after diagnosis. Among them, chemiluminescence immu...
Autores principales: | Zhan, Yan, Zhu, Yufang, Wang, Shanshan, Jia, Shijun, Gao, Yunling, Lu, Yingying, Zhou, Caili, Liang, Ran, Sun, Dingwen, Wang, Xiaobo, Hou, Zhibing, Hu, Qiaoqiao, Du, Peng, Yu, Hao, Liu, Chang, Cui, Miao, Tong, Gangling, Zheng, Zhihua, Xu, Yunsheng, Zhu, Linyu, Cheng, Jin, Wu, Feng, Zheng, Yulan, Liu, Peijun, Hong, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512652/ https://www.ncbi.nlm.nih.gov/pubmed/34645784 http://dx.doi.org/10.1038/s41392-021-00777-z |
Ejemplares similares
-
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
por: Wang, Nan, et al.
Publicado: (2020) -
Finite neutralisation breadth of omicron after repeated vaccination
por: Zhu, Yufang, et al.
Publicado: (2022) -
Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines
por: Zhu, Yufang, et al.
Publicado: (2022) -
Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness
por: Jiang, Li, et al.
Publicado: (2023) -
Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19
por: Lu, Yingying, et al.
Publicado: (2021)